SER
Serina Therapeutics·AMEX
--
--(--)
--
--(--)
0.80 / 10
Underperform
The company exhibits subpar fundamental metrics (0.8/10). Strengths observed in Net profit attributable to parent company shareholders / Net profit (%), however risks emerge in Revenue-MV and Current assets turnover ratio. Lead to constrained appraisal.
Analysis Checks(1/10)
Revenue-MV
Value-0.26
Score0/3
Weight9.21%
1M Return-2.92%
Value-0.26
Score0/3
Weight9.21%
1M Return-2.92%
Total operating revenue (YoY growth rate %)
Value85.71
Score0/3
Weight13.82%
1M Return-6.59%
Value85.71
Score0/3
Weight13.82%
1M Return-6.59%
Net income-Revenue
Value-0.17
Score1/3
Weight1.90%
1M Return-0.69%
Value-0.17
Score1/3
Weight1.90%
1M Return-0.69%
Current assets turnover ratio
Value0.02
Score1/3
Weight4.63%
1M Return-1.72%
Value0.02
Score1/3
Weight4.63%
1M Return-1.72%
Asset-MV
Value-0.50
Score1/3
Weight1.58%
1M Return-0.51%
Value-0.50
Score1/3
Weight1.58%
1M Return-0.51%
Net profit attributable to parent company shareholders / Net profit (%)
Value99.79
Score2/3
Weight4.26%
1M Return-1.63%
Value99.79
Score2/3
Weight4.26%
1M Return-1.63%
Net cash flow from operating activities / Operating revenue (%)
Value-9170.77
Score0/3
Weight15.95%
1M Return-7.70%
Value-9170.77
Score0/3
Weight15.95%
1M Return-7.70%
Net profit margin (%)
Value-12214.62
Score0/3
Weight16.62%
1M Return-8.03%
Value-12214.62
Score0/3
Weight16.62%
1M Return-8.03%
EBIT / Total operating revenue (%)
Value-12203.08
Score0/3
Weight15.72%
1M Return-7.44%
Value-12203.08
Score0/3
Weight15.72%
1M Return-7.44%
Net profit / Total operating revenue (%)
Value-12214.62
Score0/3
Weight16.30%
1M Return-7.85%
Value-12214.62
Score0/3
Weight16.30%
1M Return-7.85%
Revenue-MV
Value-0.26
Score0/3
Weight9.21%
1M Return-2.92%
Value-0.26
Score0/3
Weight9.21%
1M Return-2.92%
Net profit attributable to parent company shareholders / Net profit (%)
Value99.79
Score2/3
Weight4.26%
1M Return-1.63%
Value99.79
Score2/3
Weight4.26%
1M Return-1.63%
Total operating revenue (YoY growth rate %)
Value85.71
Score0/3
Weight13.82%
1M Return-6.59%
Value85.71
Score0/3
Weight13.82%
1M Return-6.59%
Net cash flow from operating activities / Operating revenue (%)
Value-9170.77
Score0/3
Weight15.95%
1M Return-7.70%
Value-9170.77
Score0/3
Weight15.95%
1M Return-7.70%
Net income-Revenue
Value-0.17
Score1/3
Weight1.90%
1M Return-0.69%
Value-0.17
Score1/3
Weight1.90%
1M Return-0.69%
Net profit margin (%)
Value-12214.62
Score0/3
Weight16.62%
1M Return-8.03%
Value-12214.62
Score0/3
Weight16.62%
1M Return-8.03%
Current assets turnover ratio
Value0.02
Score1/3
Weight4.63%
1M Return-1.72%
Value0.02
Score1/3
Weight4.63%
1M Return-1.72%
EBIT / Total operating revenue (%)
Value-12203.08
Score0/3
Weight15.72%
1M Return-7.44%
Value-12203.08
Score0/3
Weight15.72%
1M Return-7.44%
Asset-MV
Value-0.50
Score1/3
Weight1.58%
1M Return-0.51%
Value-0.50
Score1/3
Weight1.58%
1M Return-0.51%
Net profit / Total operating revenue (%)
Value-12214.62
Score0/3
Weight16.30%
1M Return-7.85%
Value-12214.62
Score0/3
Weight16.30%
1M Return-7.85%
Is SER undervalued or overvalued?
- SER scores 0.80/10 on fundamentals and holds a Premium valuation at present. Backed by its -1507.71% ROE, -16061.21% net margin, -1.38 P/E ratio, 16.04 P/B ratio, and -128.05% earnings growth, these metrics solidify its Underperform investment rating.
